Navigation Links
Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki
Date:5/17/2009

PARIS, May 18 /PRNewswire/ -- Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces that its two most advanced pipeline products NXL104 and NXL103 are the subject of four posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). The ECCMID conference is taking place in Helsinki between 16th and 19th May 2009.

NXL104, Novexel's broad spectrum class A and C beta-lactamase inhibitor, is the subject of one poster. Novexel is currently conducting two Phase II clinical trials in patients with complicated urinary tract infections and complicated intra-abdominal infections with NXL104 in combination with ceftazidime. The poster provides in vitro data showing that a ceftazidime/NXL104 combination is rapidly bactericidal against a range of beta-lactamase-producing strains of Enterobacteriaceae, including E. coli, and Klebsiella. Data presented also showed that one of the most important factors affecting the pharmacodynamics of the combination is maintaining a critical concentration of the inhibitor (NXL104) to suppress beta-lactamase activity. (Poster P 1463).

NXL103, a novel oral streptogramin antibiotic, is the subject of three posters at the ECCMID conference. Novexel has recently completed a successful Phase II study with NXL103 in patients with community acquired pneumonia. The first of the three posters provides in vitro data showing that NXL103 was active against methicillin resistant Staphylococcus aureus (MRSA) and organisms responsible for lower respiratory tract infections, including Streptococcus pneumoniae and Haemophilus influenzae , (Poster P 1393). The second poster contains in vivo data demonstrating that, following oral administration, NXL103 was able to kill intracellular drug-resistant and non-drug-resistant strains o
'/>"/>

SOURCE Novexel
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Novexels NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)
2. Novexels NXL104/ceftazidime Combination Commences Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections
3. Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting
4. Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia
5. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
6. Pixantrone Phase 3 Data to be Presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting
7. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
8. TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
9. TargeGen Announces Successful Completion of Patient Enrollment in Clinical Trial of JAK2 Inhibitor TG101348 in Myelofibrosis Patients and Scheduled Presentation of Preliminary Trial Data at EHA Conference in Berlin
10. Autism Studies Presented at Mid-Atlantic Research Consortium Meeting
11. Three Clinical Presentations on Tapentadol Extended Release Tablets for Chronic Pain Featured at 2009 American Pain Society Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013 /PRNewswire-iReach/ -- Today leading web researchers Change ... ranking Pharmaceutical web sites for usability, engagement, and conversion. ... Cloud platform, which compares how people experience sites with ... The top three performers are easier to ... The bottom performers have usability problems, lack aspects of ...
(Date:6/19/2013)... Calif. , June 19, 2013 ... management solutions, introduced the next-generation of its ... which allows health plans to provide their employer ... populations, health factors, medical and prescription drug claims, ... (Logo: http://photos.prnewswire.com/prnh/20100621/SF23660LOGO ) ...
(Date:6/18/2013)... Quebec , June 18, 2013 Valeant ... TSX: VRX) (the "Company") announced today that VPII Escrow ... the Company, has launched its offer of approximately $3.2 ... "Notes").  The Notes will be due in 2021 and ... The Company intends to use the net proceeds ...
Breaking Medicine Technology:Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall 2MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3
... CLEVELAND, Feb. 10, 2011 Medicare beneficiaries are reporting ... following the January 1, 2011 implementation of Medicare,s "competitive" ... many of the more than 640,000 seniors and people ... enrolled in Medicare. The bidding program began ...
... 2011 USANA Health Sciences, Inc. (NYSE: ... gaps are common in the average American diet and that ... gaps.  However, USANA scientists and advising physicians caution that many ... Dietary Guidelines for Americans, 2010 and that ...
Cached Medicine Technology:Seniors in Ohio Report Problems With Access to Home Medical Equipment and Services Under Controversial Medicare Bidding System 2Seniors in Ohio Report Problems With Access to Home Medical Equipment and Services Under Controversial Medicare Bidding System 3USDA Recognizes Benefit of Supplements in New Dietary Guidelines But Doesn't Go Far Enough 2
(Date:6/19/2013)... Imprivata ®, a leading global provider of ... OneSign ® leads the single sign-on (SSO) category in ... Services report . CIOs and other healthcare executives iwere ... of its products and the quality of its customer ... integral to their long-term healthcare IT strategy. , ...
(Date:6/19/2013)... According to Transparency Market Research “Endoscopy devices Market ... Forecast, 2011 – 2017,” the global endoscopy devices market ... and is expected to reach USD 10.8 billion by ... to 2017. Flexible endoscopes formed the largest category in ... for the year 2011. , Related Report : Medical ...
(Date:6/19/2013)... the fact that the incidence of cancer is many ... we still have an inadequate understanding on how best ... elderly patients are occasionally included in clinical trials, those ... (fit) elderly patients. Thus, the broader elderly patient population ... Cancer in the Elderly Task Force is now starting ...
(Date:6/19/2013)... Ethigen announced today the US launch ... , providing next-generation sequencing (NGS) and rearrangement analysis of ... of an expanded hereditary cancer panel, including full coverage ... to cancer risk: MLH1, MSH2, MSH6, APC, MUTYH (MYH), ... FLCN, PDGFRA, and KIT. , The expanded panel ...
(Date:6/19/2013)... Angeles, California (PRWEB) June 19, 2013 ... for iPhone, a free music and fitness app for ... you can discover new Spotify songs that match your ... when they exercise, and add songs to your favorite ... and songs curated by the GoTunes staff. , Get ...
Breaking Medicine News(10 mins):Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 2Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 3Health News:EORTC study opens for elderly patients with HER-2 positive metastatic breast cancer 2Health News:Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel 2Health News:Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel 3Health News:The GoTunes Iphone App Creates a Streaming Workout Music Community Via Spotify 2
... on Jammu and Kashmir by humanitarian group Médecins Sans Frontières ... distress and more than one in 10 had been victims ... ,The report by the Holland-based MSF is based ... weeks in mid-2005. The survey group defined 1989 as the ...
... Institute of Mental Health (NIMH) helps in improving the ... pediatric bipolar disorder (BD) and severe mood dysregulation (SMD). ... measured during mildly frustrating situations, researchers found a very ... who had BD. The results indicate that different brain ...
... bird flu expert Dr.David Nabarro, Senior U.N. Coordinator for Avian and ... // ,Speaking from Indonesia where he is attending a bird ... expected up to May, as this is the time when ... last a turkey farm at Suffolk, UK was witness to the ...
... passion for surgeries without taking a break has helped a ... //using his unique technique of single hole surgery. ... in Agra at around 10 p.m. Thursday night and continued ... 45 gall bladders and five appendixes, with his surgery technique, ...
... choice is coffee, recent research provides an //extra perk. ... garnered considerable attention due to its high antioxidant content, ... antioxidants. Antioxidants are generally helpful substances, found in foods, ... Free radicals contribute to oxidative stress, which, over time, ...
... lipid plays a big role in helping us grow from ... have found. ,They found that in the first ... to form the primitive ectoderm from which embryonic tissues develop, ... Georgia. ,Probably 90 percent of ceramide gathers at ...
Cached Medicine News:Health News:Mental Health of Kashmiris Needs Urgent Attention: Survey 2Health News:Is Extreme Irritability - a Childhood Bipolar Disorder? 2Health News:Is Extreme Irritability - a Childhood Bipolar Disorder? 3Health News:Coffee: Is It Good or Bad for You? 2Health News:Lipid Plays Big Role in Embryonic Development 2
... simple intuitive programming and almost completely noiseless ... personal cycler in the modern laboratory workplace. ... self-adjusting heated lid allows a choice of ... a microplate of 5 x 5 in ...
... temperature cyclers, the gradient block can be set ... to 14 or 22 across the 40- or ... up to 2C between adjacent wells in each ... 12 different annealing temperatures in a single experiment. ...
... Mx3005P instrument and custom filter wheels ... filters. The standard filter set includes: ... ROX/Texas Red (585nm-610nm), Cy5 (635nm-665nm) and ... Mx3005P analysis software, Beacon Designer oligo ...
... is a rapid, real-time thermal cycler used ... By automating much of the testing process, ... it is the fastest, easiest to use, ... market. The SmartCycler delivers highly accurate and ...
Medicine Products: